Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1999-02-26
1999-11-16
Degen, Nancy
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 6, 4352521, 4353201, 435325, 435455, 536 235, C07H 2104, C12N 1511, C12N 1585, C12N 120
Patent
active
059860782
ABSTRACT:
The invention provides novel tumor suppressor genes, methods for making and using these and related tumor suppressor genes and proteins and peptides, and nucleic acids encoding these and related tumor suppressor proteins and peptides.
REFERENCES:
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
Aharon, T., et al., "Selective Destabilization of Short-Lived mRNAs with the Granulocyte-Macrophage Colony-Stimulating Factor AU-Rich 3' Noncoding Region is Mediated by a Cotranslational Mechanism", Mol. Cell. Biol., 13:1971-1980 (1993).
Atadja, P., et al., "Increased activity of p53 in senescing fibroblasts", Proc. Nat'l. Acad. Sci. USA, 92:8348-8352 (1995).
Bond, et al., "Escape from senescence in human diploid fibroblasts induced directly by mutant p53", Oncogene., 9:1885-1889 (1994).
Defeo-Jones, D., "Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product", Nature, 352:251-254 (1991).
Demetrick, D.J., "Fluorescence in situ hybridization and human cell cycle genes", In the Cell Cycle--Materials and Methods, M. Pagano (ed.), Springer Verlag Press, 29-45 (1995).
El-Deiry, W.S., et al., "WAF1, a Potential Mediator of p53 Tumor Suppression", Cell, 75:817-825 (1993).
Garkavtsev, et al., "Suppression of the novel growth inhibitor p33.sup.ing1 promotes neoplastic transformation", Nature Genetics, 14(4):415-420 (1996).
Grudkov, A., et al., "Cloning mammalian genes by expression selection of genetic suppressor elements: Associate of kinesin with drug resistance and cell immortalization", Proc. Nat'l Acad. Sci. USA, 91:3744-3798 (1994).
Guan, K., et al., "Growth suppression by p18, a p16.sup.INK4/MTS1 and p14.sup.INK4B/MTS2 -related CDK6 inhibitor, correlates with wild-type pRb function", Genes & Dev., 8:2939-2952 (1994).
Gudkov, A.V., et al., "Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA", Proc. Natl. Acad. Sci. USA, 90:3231-3235 (1993).
Harper, J.W., et al., "The p21 Cdk-Interacting Protein Cip1 is a Potent Inhibitor of G1 Cyclin-Dependent Kinases", Cell, 75:805-816 (1993).
Hillier, et al., "Database EMBL Entry HS12525", WashU-EST Project (Feb. 1995).
Hillier, et al., "Database EST on MPSRCH, Accession No. T60985", WashU-Merck EST Project (Feb. 1995).
Hunter, T., et al., "Cyclins and Cancer II: Cyclin D and CDK Inhibitors Come to Age", Cell, 79:573-582 (1994).
Kamb, A., et al., "A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types", Science, 264:436-440 (1994).
Levine, A.J., "The Tumor Suppressor Genes", Annu. Rev. Biochem., 62:623-651 (1993).
Lisitsyn, N., et al., "Cloning the Differences Between Two Complex Genomes", Science, 259:946-951 (1993).
Maestro, et al., "Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss", Cancer Res., 56:1146-1150 (1996).
Miller, A.D., et al., "Improved Retroviral Vectors for Gene Transfer and Expression", Biotechniques, 7:980-986 (1989).
Mitelman, et al., "Report of the committee on chromosome changes in neoplasia", Cytogenet. Cell Genet., 55:358-386 (1990).
Motomura, et al.,"Loss of alleles at loci on chromosome 13 in human primary gastric canders", Genomics, 2:180-184 (1988).
Nobori, T., et al., "Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers", Nature, 368:753-756 (1994).
Pear, W.S., et al., "Production of high titer helper-free retroviruses by transient transfection", Proc. Natl. Acad. Sci., 90:8392-8396 (1993).
Riabowol, K., et al., "The cdc2 Kinase Is a Nuclear Protein That Is Essential for Mitosis in Mammalian Cells", Cell, 57:393-401 (1989).
Schneider, E..L., et al., "Measurement of a DNA content and cell volume in senescent human fibroblasts utilizing flow miltiparameter single cell analysis", Exp Cell. Res., 98:298-302 (1976).
Serrano, M., et al., "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4", Nature, 366:704-707 (1993).
Straus, D., et al., "Genomic subtraction for cloning DNA corresponding to deletion mutations", Proc. Natl. Acad. Scl. USA, 87:1889-1893 (1990).
Thompson, M.E., et al., "Decreased expression of BRCA-1 accelerates growth and is often present during sporadic breast cancer progression", Nature Genetics, 9:444-450 (1995).
Tsai, L.H., et al., "The cdk2 kinase is required for the G1- to -S transition in mammalian cells", Oncogene., 8:1593-1602 (1993).
Weinberg, Robert A., "Tumor Suppressor Genes", Science, 254:1138-1146 (1991).
Wong, H., et al., "Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method", Anal. Biochem., 223:251-258 (1994).
Xlong, et al., "p21 is a Universal Inhibitor of Cyclin Kinases", Nature, 366:701-704 (1993).
Yang, Y., et al., "An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer", Proc. Nat'l. Acad. Sci. USA, 90: 4601-4605 (1993).
Yaswen, P., et al., "Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells", Proc. Natl. Acad. Scl. USA, 87:7360-7364 (1990).
Garkavtsev Igor
Riabowol Karl
Degen Nancy
McGarry Sean
University Technologies International Inc.
LandOfFree
DNA sequence encoding the tumor suppressor gene ING1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA sequence encoding the tumor suppressor gene ING1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA sequence encoding the tumor suppressor gene ING1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326379